FIGS, Inc. (FIGS) AI Stock Analysis

FIGS, Inc. is a direct-to-consumer company based in Santa Monica, California, specializing in healthcare apparel and lifestyle products. Founded in 2013, the company designs innovative garments primarily for healthcare professionals across the United States. Its core offering includes scrubs, lab coats, under scrubs, and compression socks. FIGS also provides non-scrub apparel such as outerwear, activewear, loungewear, footwear, and masks designed for comfort, durability, and style. The company markets and sells its products through a digital platform consisting of its website and mobile app, creating direct relationships with customers.

FIGS expanded revenue from $419.6M in FY2021 to $631.1M in FY2025, delivering a 5-year revenue CAGR of 19.1%. Revenue growth slowed from 59.5% in FY2021 to 1.8% in FY2024 before accelerating to 13.6% in FY2025. Gross margin contracted from 71.8% in FY2021 to 66.5% in FY2025. Net income was -$9.6M in FY2021, reached $2.7M in FY2024, and rebounded to $34.2M in FY2025 with a net margin of 5.4%. For the latest quarter ended June 30, 2026, quarterly revenue grew 28.8% year-over-year and quarterly earnings grew 275.0%. Over the trailing twelve months, revenue totaled $710.1M and operating margin was 17.9%.

As of June 30, 2026, FIGS held $296.3M in cash and short-term investments against total debt of $57.7M, resulting in net cash of $238.6M. The company maintained a current ratio of 4.96 and a debt-to-equity ratio of 0.13, supported by $442.4M in shareholders' equity. In FY2025, FIGS generated $61.2M in operating cash flow and $53.0M in free cash flow. Capital allocation in FY2025 included $8.2M in capital expenditures and $2.7M in share buybacks.

FIGS closed at $19.12 on October 16, 2026, trading at a trailing P/E of 57.9x and a forward P/E of 31.5x, compared to the median of its US-listed Consumer Cyclical peers at 18.0x and 14.1x, respectively. The enterprise value to EBITDA ratio is 22.2x, above the peer median of 11.1x, while its price-to-sales ratio is 4.5x compared to the peer median of 0.7x. Over the past year, FIGS stock returned 148.6%, outperforming the S&P 500 (SPY) return of 16.8%, though its 5-year return of -47.4% lagged the benchmark return of 83.0%.

Wall Street analysts maintain 4 Strong Buy, 1 Buy, and 4 Hold ratings on FIGS, with zero Sell or Strong Sell recommendations. The mean price target is $18.62, representing a 2.6% decline from the closing price of $19.12. For the fiscal year ending December 31, 2026, consensus estimates project EPS of $0.36 on revenue of $761.0M. For the following fiscal year, 7 analysts project EPS of $0.38 and revenue of $831.1M. FIGS has exceeded EPS expectations in each of the last 4 quarters, with next earnings scheduled for November 5, 2026.

This page is an AI-written research summary of FIGS, Inc. (FIGS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: FIGS income statement, FIGS balance sheet, FIGS key metrics, FIGS analyst forecast, FIGS chart. See the FIGS stock overview for the latest quote and news.